Alex Immerman

Now Live: "We’re at the Beginning of a New Industrial Age" – Erin Price-Wright, Andreessen Horowitz🎙️ Today on #COBT we had the pleasure of hosting Erin Price-Wright, General Partner in American Dynamism at Andreessen Horowitz (a16z). Erin joined a16z from Index Ventures in 2024, where she was a Partner focused on software infrastructure and applied AI. She previously served as Head of Product for Palantir’s data analytics and machine learning program. The American Dynamism practice invests in founders and companies that support the national interest spanning aerospace, defense, public safety, education, housing, supply chain, industrials, and manufacturing. We were thrilled to hear Erin’s perspective on the rapidly evolving intersection of AI, energy, and industrial technology. ▶️ Watch the episode here: https://lnkd.in/gHziUtYK ▶ Apple podcasts: https://lnkd.in/gtf4Gx8F ▶️ Spotify: https://lnkd.in/gwAGSPSs Maynard Holt | Mike Bradley | Jeff Tillery | Arjun Murti | Robert Kester | Erin Price-Wright | Andreessen Horowitz | Paul Oates | Morgan Gress

37

4 Comments

A big milestone today for Grow Therapy, which just announced a $150M Series D led by TCV and Growth Equity at Goldman Sachs Alternatives, with BCI and Menlo Ventures joining Sequoia, Transformation Capital, and SignalFire. When we led Grow’s Series A in 2021, it was rooted in a belief that mental health access in the U.S. isn’t hindered by supply, it’s a systems problem. To win, Grow needed to be deeply integrated into the healthcare ecosystem, not operating as a point solution. In just 5 years, more than 2 million people have used Grow, with over 10 million therapy and medication management visits delivered on the platform. What stands out is the infrastructure the team has built: Grow now partners with 125+ health insurers, including Medicare and Medicaid across most states, reaching 220 million covered lives. At the same time, tools like its clinically-guided AI notetaker are reducing provider documentation time by nearly 70%, helping clinicians focus more on care. This is what durable healthtech looks like: deep payer integrations, measurable outcomes, and technology embedded directly into existing healthcare workflows. Excited to continue partnering with Jake Cooper, Manoj Kanagaraj, MD, Alan Ni, and the entire Grow team as they build trusted mental health infrastructure for insurers, employers, health systems, and most importantly, patients.

472

19 Comments

Former a16z speedrun partner Bryan Kim launches $100M Mido Capital Bryan Kim, a former partner at Andreessen Horowitz, is launching #Mido Capital, a new venture firm targeting approximately $100 million for its debut fund. The Delaware entity was formed in July 2026, three months after Kim announced his departure from a16z. Mido Capital will focus on early stage consumer AI and adjacent technology companies, primarily at seed and Series A. Kim spent more than five years at a16z, where his investments included ElevenLabs, Function Health, Partiful, SlingshotAI, Captions, BeReal, Raspberry AI and Cluely. He led a $15 million investment in Cluely in 2025. Mido’s limited partners and check sizes have not been disclosed, and the $100 million target has not yet been reported as closed. The article on #fundmomentum in the first comment.

47

3 Comments

Announcing our portco Zeno has raised next round of $25mn with participation from Congruent Ventures Lowercarbon Capital Trifecta Capital ! Advantedge Founders continues to back the team with $2mn additional investment. Its been terrific working with Michael Spencer & Greg Moran to establish the full stack model in Africa. With this raise expansion in new markets and planning for India launch is next steps. https://lnkd.in/gGr6qiBj

74

2 Comments

Wealth professionals looking to introduce private market investments into client portfolios are finding that client education is essential. Managing Director James Martin shares a key insight from our Global Private Wealth Survey that highlights how stronger education equips clients to confidently embrace private markets.

17